Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-06-03
2008-06-03
Zara, Jane (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S006120, C435S091100, C435S091310, C435S455000, C536S023100, C536S024500
Reexamination Certificate
active
07381708
ABSTRACT:
The present invention provides methods for preventing retinal ganglion cell death in the glaucomatous eye and methods for suppressing apoptosis-specific eIF5A1 expression through the use of antisense oligonucleotides targeted to human apoptosis-specific eIF5A1.
REFERENCES:
patent: 2003/0225022 (2003-12-01), Taylor et al.
patent: 94/15596 (1994-07-01), None
patent: WO 96/25492 (1996-08-01), None
patent: 96/41639 (1996-12-01), None
patent: WO 99/01551 (1999-01-01), None
patent: 01/02592 (2001-01-01), None
patent: WO 01/10906 (2001-02-01), None
patent: WO 03/010286 (2003-02-01), None
patent: WO 03/095613 (2003-11-01), None
patent: 2004/078940 (2004-09-01), None
patent: 2005/007853 (2005-01-01), None
Braasch, D. A. Biochemistry. Apr. 2002; 41(14): 4503-4510.
Branch, A. D.,Trends Biochem Sci. Feb. 1998;23(2):45-50.
Opalinska and Gewirtz Nature Reviews, 2002. 1:503-514.
Jen et al. (Stem Cells 2000, vol. 18, p. 307-319).
Tamm, I. et al. The Lancet. 2001, Aug. 358: 489-497.
Jin, Bao-Feng et al., “Proteomic analysis of ubiquitin-proteasome effects: insight into the future of eukaryotic initiation factor 5A,” ONCOGENE, Jul. 31, 2003, pp. 4819-4830, vol. 22, No. 31, Nature Publishing Group, XP-002388453, ISSN: 0950-9232.
Annexes to Form PCT/ISA/206, Invitation to Pay Additional Fees, Communication Relating to the Results of the Partial International Search, PCT/US2005/044266, Aug. 11, 2006, comprised of the Annex first, continuation and 4th of 5 extra sheets and the Patent Family Annex, European Patent Office, International Searching Authority, Rijswijk, NL.
Tome M E et al: “Excess putrescine accumulation inhibits the formation of modified eukaryotic initiation factor 5A (eIF-5A) and induces apoptosis”, Biochemical Journal, Portland Press, London, GB, vol. 328, pp. 847-854, 1997, ISSN: 0264-6021.
Database EMBL (Online) Dec. 14, 1999, “uo59b11.y1 NCI—CGAP—Mam1 Mus musculus cDNA clone, Image: 2646813 5′ similar to gb:M23419 Initiation Factor 5A (Human);, mRNA sequence”, retrieved from EBI accession No. EM—PRO:AW229460.
Bevec Dorian et al: “Molecular characterization of a cDNA encoding functional human deoxyhypusine synthase and chromosomal mapping of the corresponding gene locus”, FEBS Letters, vol. 378, No. 2, 1996, pp. 195-198, ISSN: 0014-5793.
Database EMBL (Online) Dec. 11, 1995, “Human deoxyhypusine synthase mRNA, complete cds.” retrieved from EBI accession No. EM—HUM:U40579.
Wolff Edith C et al: “Deoxyhypusine synthase from rat testis: Purification and characterization”, Journal of Biological Chemistry, vol. 270, No. 15, 1995, pp. 8660-8666, ISSN: 0021-9258.
Joe Young Ae et al: “Cloning and expression of human deoxyhypusine synthase cDNA: Structure-function studies with recombinant enzyme and mutant proteins”, Journal of Biological Chemistry, vol. 270, No. 38, 1995, pp. 22386-22392, ISSN: 0021-9258.
Database EMBL (Online) Jul. 7, 2000, “hv36b09.x1 NCI—CGAP—Lu24Homo sapienscDNA clone, Image:3175481 3′ similar to SW:DHYS—Human P49366 Deoxyhypusine Synthase ;, mRNA sequence.” retrieved from EBI accession No. EM—EST:BE218247.
Caraglia et al., “The role of eukaryotic initiation factor 5A in the contori of cell proliferation and apoptosis,” Amino Acids, (2001) 20: pp. 91-104.
Chen, et al., “RNA interference analysis of the function of hypusine-containing eukaryotic initiation factor 5A in C. elegans”, FASEB Journal, Mar. 20, 2002, vol. 16, No. 4; Annual Meeting of the Professional Research Scientists on Experimental Biology; New Orleans, LA, USA, Apr. 20-24, 2002, XP008033807.
Hayashizaki et al., “Analysis of the Mouse Transcriptome Based on Functional Annotation of 60,770 Full-Length cDNAs,” Nature, United Kingdom, vol. 420, No. 6915, pp. 563-573, ISSN: 0028-0836, XP002965277, Dec. 5, 2002.
Cliche Dominic
Flanagan John Gerard
Heikkila Elizabeth Margaret
Senchyna Diane Michelle
Taylor Catherine
Sensco Technologies, Inc.
Womble Carlyle Sandridge & Rice PLLC
Zara Jane
LandOfFree
Suppression of eIF5A1 expression by the use of antisense... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Suppression of eIF5A1 expression by the use of antisense..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppression of eIF5A1 expression by the use of antisense... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2799957